España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Alkermes
ALKS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$29.71
-0.26
-0.87%
At close: -
$31.51
1.80
6.07%
After Hours: Dec 20, 6:34 PM EDT
Get Report
Comment
Alkermes (ALKS) Forecast
News
Earnings
Alkermes (ALKS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Alkermes (NASDAQ:ALKS) Stock
Alkermes Stock (NASDAQ: ALKS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, November 13, 2024
Mizuho Maintains Outperform on Alkermes, Rais...
Benzinga Newsdesk
Tuesday, November 05, 2024
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts
Benzinga Insights
Stifel Upgrades Alkermes to Buy, Raises Price...
Benzinga Newsdesk
Friday, October 25, 2024
Goldman Sachs Maintains Buy on Alkermes, Lowe...
Benzinga Newsdesk
Cantor Fitzgerald Maintains Overweight on Alk...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Alkermes, Lowe...
Benzinga Newsdesk
Piper Sandler Reiterates Overweight on Alkerm...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Alk...
Benzinga Newsdesk
Thursday, October 24, 2024
Alkermes Q3 2024 GAAP EPS $0.56 Misses $0.59 ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Alkermes's Earnings: A Preview
Benzinga Insights
Monday, October 14, 2024
HC Wainwright & Co. Reiterates Neutral on Alk...
Benzinga Newsdesk
Thursday, October 10, 2024
Decoding 7 Analyst Evaluations For Alkermes
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk
Monday, September 23, 2024
Alkermes Announced Plans To Present Clinical ...
Benzinga Newsdesk
Monday, September 16, 2024
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk
Thursday, August 22, 2024
Alkermes Announces Initiation Of Vibrance-2 P...
Benzinga Newsdesk
Wednesday, July 31, 2024
Alkami Sees Q3 Total Revenue $83.8M-$85.3M vs...
Benzinga Newsdesk
Thursday, July 25, 2024
Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Alkermes, Rais...
Benzinga Newsdesk
Baird Maintains Outperform on Alkermes, Raise...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Neutral on Alke...
Benzinga Newsdesk
Wednesday, July 24, 2024
Alkermes Lags Q2 Earnings Estimates
Zacks
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Alkermes shares are trading higher after the ...
Benzinga Newsdesk
Alkermes Q2 2024 Adj EPS $0.72 Beats $0.70 Es...
Benzinga Newsdesk
Monday, July 15, 2024
6 Analysts Assess Alkermes: What You Need To Know
Benzinga Insights
JP Morgan Maintains Neutral on Alkermes, Lowe...
Benzinga Newsdesk
Monday, June 24, 2024
Orchestra BioMed Holdings, Inc. Stock Jumps 7.3%: Will It Continue to Soar?
Zacks
Monday, June 17, 2024
The Analyst Landscape: 7 Takes On Alkermes
Benzinga Insights
TD Cowen Initiates Coverage On Alkermes with ...
Benzinga Newsdesk
Tuesday, June 04, 2024
HC Wainwright & Co. Reiterates Neutral on Alk...
Benzinga Newsdesk
Monday, June 03, 2024
Alkermes Unveils Phase 1b Data for Narcolepsy...
Benzinga Newsdesk
Tuesday, May 28, 2024
Alkermes to Present Promising Narcolepsy Trea...
Benzinga Newsdesk
Thursday, May 23, 2024
6 Analysts Assess Alkermes: What You Need To Know
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on Alk...
Benzinga Newsdesk
Thursday, May 02, 2024
7 Analysts Assess Alkermes: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Alk...
Benzinga Newsdesk
Alkermes Has Completed The Previously Announc...
Benzinga Newsdesk
Wednesday, May 01, 2024
Alkermes Q1 2024 Adj EPS From Continuing Oper...
Benzinga Newsdesk
Alkermes Reiterates Its Financial Expectation...
Benzinga Newsdesk
Alkermes Q1 Sales $350.372M Miss $360.258M Es...
Benzinga Newsdesk
Wednesday, April 24, 2024
Alkermes Expects To Initiate Vibrance-2 Phase...
Benzinga Newsdesk
Alkermes Initiates Vibrance-1 Phase 2 Study O...
Benzinga Newsdesk
Friday, April 19, 2024
HC Wainwright & Co. Reiterates Neutral on Alk...
Benzinga Newsdesk
Tuesday, April 09, 2024
Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
Vandana Singh
Breaking Down Alkermes: 5 Analysts Share Their Views
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch